Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trastuzumab deruxtecan for brain cancer, including glioblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Glioblastoma
• Leptomeningeal Metastasis

Drugs mentioned

• Trastuzumab deruxtecan (trastuzumab deruxtecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain Cancer, Glioblastoma | Phase 2 | Status: RECRUITING